Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00619996
What this trial is testing

Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Italian Trial in Medical Oncology 43
Early research (Phase 1)Study completedNCT02151760
What this trial is testing

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 37
Testing effectiveness (Phase 2)Ended earlyNCT00048659
What this trial is testing

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Who this might be right for
Hormone-Refractory Prostate CancerProstatic Neoplasms
Astellas Pharma Inc
Early research (Phase 1)Looking for participantsNCT05818683
What this trial is testing

Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate NeoplasmsMetastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC 300
Early research (Phase 1)Study completedNCT04086966
What this trial is testing

PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study

Who this might be right for
Metastatic Prostate Cancer
University of Alabama at Birmingham 10
Testing effectiveness (Phase 2)Ended earlyNCT00527124
What this trial is testing

Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateStage IV Prostate Cancer
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00258388
What this trial is testing

Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05717582
What this trial is testing

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Who this might be right for
Metastatic Prostate CancerCastration-Sensitive Prostate Cancer
Fudan University 47
Testing effectiveness (Phase 2)UnknownNCT02913859
What this trial is testing

Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital Sestre Milosrdnice 60
Testing effectiveness (Phase 2)UnknownNCT00003717
What this trial is testing

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
St. Barnabas Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00078585
What this trial is testing

PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Bavarian Nordic 120
Large-scale testing (Phase 3)Study completedNCT01212991
What this trial is testing

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 1,717
Testing effectiveness (Phase 2)Study completedNCT00599313
What this trial is testing

Phase II Sunitinib Prog Met AIPC

Who this might be right for
Metastatic Prostate Cancer
US Oncology Research 36
Not applicableLooking for participantsNCT05933876
What this trial is testing

The Impact of Radiotherapy on Oligometastatic Cancer

Who this might be right for
MetastasisMetastatic Breast CancerMetastatic Prostate Cancer+2 more
Institut Investigacio Sanitaria Pere Virgili 2,000
Early research (Phase 1)Active Not RecruitingNCT06303713
What this trial is testing

LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 37
Early research (Phase 1)Study completedNCT03793543
What this trial is testing

Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05367440
What this trial is testing

Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT04343885
What this trial is testing

In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy

Who this might be right for
Metastatic Hormone Naive Prostate Cancer
Peter MacCallum Cancer Centre, Australia 130
Testing effectiveness (Phase 2)Ended earlyNCT03770455
What this trial is testing

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Jodi Layton, MD 8
Testing effectiveness (Phase 2)Study completedNCT01498978
What this trial is testing

Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 10
Next Page